P.E. Keane

1.7k total citations
41 papers, 1.4k citations indexed

About

P.E. Keane is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Social Psychology. According to data from OpenAlex, P.E. Keane has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 5 papers in Social Psychology. Recurrent topics in P.E. Keane's work include Neuroscience and Neuropharmacology Research (21 papers), Receptor Mechanisms and Signaling (13 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). P.E. Keane is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Receptor Mechanisms and Signaling (13 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). P.E. Keane collaborates with scholars based in France, Italy and United Kingdom. P.E. Keane's co-authors include Jacques Simiand, Michel Morre, M. Strolin Benedetti, Jean-Claude Vernières, Archie C. Chapman, Brian S. Meldrum, Francesco Crespi, Kathleen Bizière, Philippe Soubrié and Jacqueline Fournier and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Neuroscience.

In The Last Decade

P.E. Keane

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.E. Keane France 20 748 459 257 253 180 41 1.4k
Z Kleinrok Poland 21 883 1.2× 477 1.0× 567 2.2× 237 0.9× 111 0.6× 81 1.3k
Nobutada Tashiro Japan 23 534 0.7× 506 1.1× 202 0.8× 238 0.9× 147 0.8× 63 1.7k
H Rosengarten United States 18 693 0.9× 488 1.1× 187 0.7× 117 0.5× 80 0.4× 34 1.2k
G. S. Sarna United Kingdom 24 962 1.3× 648 1.4× 180 0.7× 128 0.5× 264 1.5× 38 1.9k
A Dresse Belgium 23 815 1.1× 610 1.3× 195 0.8× 72 0.3× 162 0.9× 91 1.6k
L Ciesielski France 18 598 0.8× 360 0.8× 210 0.8× 213 0.8× 165 0.9× 66 1.3k
Ágnes Rimanóczy Hungary 25 460 0.6× 386 0.8× 250 1.0× 228 0.9× 271 1.5× 59 1.5k
Theodore A. Hare United States 22 691 0.9× 368 0.8× 237 0.9× 78 0.3× 208 1.2× 46 1.4k
Brian A. McMillen United States 26 1.3k 1.7× 659 1.4× 138 0.5× 280 1.1× 134 0.7× 70 1.9k
William H. Lyness United States 22 1.0k 1.4× 549 1.2× 206 0.8× 68 0.3× 167 0.9× 51 1.8k

Countries citing papers authored by P.E. Keane

Since Specialization
Citations

This map shows the geographic impact of P.E. Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.E. Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.E. Keane more than expected).

Fields of papers citing papers by P.E. Keane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.E. Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.E. Keane. The network helps show where P.E. Keane may publish in the future.

Co-authorship network of co-authors of P.E. Keane

This figure shows the co-authorship network connecting the top 25 collaborators of P.E. Keane. A scholar is included among the top collaborators of P.E. Keane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.E. Keane. P.E. Keane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaeffer, Paul, et al.. (2000). Characterisation of the effects of SR146131, a novel non-peptide CCK1 receptor agonist, on IMR-32 human neuroblastoma cells. European Journal of Pharmacology. 397(2-3). 303–310. 4 indexed citations
2.
Duong, François H.T., Jacqueline Fournier, P.E. Keane, et al.. (1998). The effect of the nonpeptide neurotrophic compound SR 57746A on the progression of the disease state of the pmn mouse. British Journal of Pharmacology. 124(4). 811–817. 25 indexed citations
3.
Pousset, F., Jacqueline Fournier, & P.E. Keane. (1997). Expression of Cytokine Genes during Ontogenesis of the Central Nervous System. Annals of the New York Academy of Sciences. 814(1). 97–107. 4 indexed citations
4.
Fournier, Jacqueline, P.E. Keane, Pascual Ferrara, & Philippe Soubrié. (1997). SR 57746A: An Orally Active Non‐Peptide Compound with Neurotrophic and Neuroprotective Effects. CNS Drug Reviews. 3(2). 148–167. 13 indexed citations
5.
Keane, P.E., et al.. (1995). Effects of the σ receptor ligand SR 31742A on neurotensin biosynthesis in rat basal ganglia. Synapse. 19(4). 241–246. 4 indexed citations
6.
Keane, P.E., et al.. (1993). The σ receptor ligand SR 31742A increases neurotensin in the nucleus accumbens but not in the caudate-putamen of the rat. European Journal of Pharmacology. 231(3). 465–467. 5 indexed citations
7.
Bachy, André, Michel Héaulme, A Giudice, et al.. (1993). SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. European Journal of Pharmacology. 237(2-3). 299–309. 70 indexed citations
8.
Fournier, Jacqueline, R. Steinberg, Thierry Gauthier, et al.. (1993). Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience. 55(3). 629–641. 60 indexed citations
9.
Simiand, Jacques, P.E. Keane, Xavier Langlois, et al.. (1992). Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical β-adrenoceptors. European Journal of Pharmacology. 219(2). 193–201. 41 indexed citations
10.
Vayssière, Jean‐Luc, et al.. (1989). Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells. European Journal of Pharmacology. 161(2-3). 197–202. 57 indexed citations
11.
Simiand, Jacques, P.E. Keane, Kathleen Bizière, & Philippe Soubrié. (1989). Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants.. PubMed. 297. 272–85. 17 indexed citations
12.
Keane, P.E., Jacques Simiand, Michel Morre, & Kathleen Bizière. (1988). Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.. Journal of Pharmacology and Experimental Therapeutics. 245(2). 692–698. 20 indexed citations
13.
Crespi, Francesco & P.E. Keane. (1987). Analysis of extracellular DOPAC, HVA and 5-HIAA in rat striatum in vivo by differential pulse voltammetry: Effect of phencyclidine, haloperidol and their coadministration. Pharmacological Research Communications. 19(9). 639–649. 4 indexed citations
14.
Keane, P.E. & Kathleen Bizière. (1987). The effects of general anaesthetics on gabaergic synaptic transmission. Life Sciences. 41(12). 1437–1448. 53 indexed citations
16.
Chapman, Archie C., P.E. Keane, Brian S. Meldrum, Jacques Simiand, & Jean-Claude Vernières. (1982). Mechanism of anticonvulsant action of valproate. Progress in Neurobiology. 19(4). 315–359. 296 indexed citations
17.
Keane, P.E., Jean Ménager, & M. Strolin Benedetti. (1981). The effect of monoamine oxidase A and B inhibitors on rat serum prolactin. Neuropharmacology. 20(12). 1157–1162. 10 indexed citations
18.
Benedetti, M. Strolin & P.E. Keane. (1980). Differential Changes in Monoamine Oxidase A and B Activity in the Aging Rat Brain. Journal of Neurochemistry. 35(5). 1026–1032. 155 indexed citations
19.
Keane, P.E., et al.. (1978). The effects of local micro injections of opiates and enkephalins into the forebrain on the electrocorticogram of the rat. Electroencephalography and Clinical Neurophysiology. 45(5). 655–665. 19 indexed citations
20.
Keane, P.E., et al.. (1977). The effect of acetylcholine and dopamine on the caudate spindle in cats. Journal of Neuroscience Research. 3(3). 209–216. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026